Group 1 - The article highlights a promising technology solution that is expected to break through the DRAM manufacturing bottleneck, with mass production anticipated by 2028. Three main lines of companies are positioned to benefit from this development [1] - The application of exoskeleton technology is expanding from medical uses to the consumer market, with a projected market size of 19.5 billion expected to reach a tipping point. Several A-share companies have already positioned themselves in key segments of this market [1]